Advance Directives for Psych Care Reduce Compulsory Admissions

Providing peer or community health workers to help psychiatric patients with complete psychiatric advance directives (PAD) to govern care in advance of a mental health crisis is associated with a significant reduction in compulsory hospital admissions, new research shows. Results of a randomized trial showed the peer worker PAD group had a 42% reduction in … Read more

Antipsychotic Tied to Weight Gain, Higher Cholesterol

Increases in use of the antipsychotic risperidone (Risperdal) are associated with small dose-related increases in both weight and blood cholesterol levels, new research suggests. Investigators analyzed 1-year data for more than 400 patients who were taking risperidone and/or its metabolite paliperidone (Invega). Results showed increments of 1 mg of risperidone-equivalent doses were associated with an … Read more

New Med for Severe Mental Illness Tied to Less Weight Gain

Olanzapine plus samidorphan (Lybalvi) vs olanzapine alone is associated with less weight gain while achieving similar clinical outcomes in patients with recent-onset severe mental illness, new research suggests. However, least one expert says the weight difference between the two drugs is of “questionable clinical benefit.” Last year, the US Food and Drug Administration (FDA) approved … Read more

New Tool Cuts CVD Risk in Patients With Serious Mental Illness

A clinical decision support (CDS) system that can be implemented in primary care reduces cardiovascular risk factors (CV) common in patients with serious mental illness (SMI), new research suggests. Investigators assessed more than 70 primary care clinics that treated close to 9000 patients with SMI. Disorders included schizophrenia, bipolar disorder, and schizoaffective disorder. The clinics … Read more